Bioxtreme Plaxtreme launches in the US
The device is being used by patients at Precision Rehabilitation. A patient story will follow.
See the latest news and media coverage for Bioxtreme. We track all announcements, press releases, and industry mentions in real time, all in one place.
Medical device manufacturer of robotic neurorehabilitation systems
bioxtremerobotics.comLast updated
In short: Bioxtreme secured $15 million in a Serra Holding-led investment and announced Plaxtreme.
The device is being used by patients at Precision Rehabilitation. A patient story will follow.
Samcon becomes the official distributor for Bioxtreme's Dextreme and Plaxtreme rehab robotics in Belgian hospitals.
CEO Eyal Samuel Shachar shares future plans. Intelligent challenges drive real recovery.
The investment from Serra Holding fuels U.S. and Europe expansion. They strengthen leadership, add advisors, and launch Plaxtreme robotic rehab solution.
Dextreme 2.0 combines patented Error Augmentation technology, adaptive AI and immersive therapy to accelerate motor recovery after neurological injury...
Chicago, IL, April 21, 2026 (GLOBE NEWSWIRE)-- Bioxtreme, an innovator in neurorehabilitation technologies leveraging its proprietary error augmentation approach to ...
Bioxtreme, an innovator in neurorehabilitation technologies leveraging its proprietary error augmentation approach to accelerate motor recovery, today announced a new strategic investment led by Serra...
Track Bioxtreme and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.